GLP-1 drugs have direct beneficial effects on the liver, independent of their benefits for obesity, researchers studying the ...
A large real-world study shows lower all-cause mortality and some cardiovascular outcomes with combination therapy; other outcomes lack statistical precision.
Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects ...
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, ...
GLP-1 drugs like Ozempic and Wegovy can aid weight loss and diabetes, but come with side effects, high costs and unanswered ...
LifeStance Health reports GLP-1 medications, known for weight loss, may also enhance mental health by improving mood, ...
The rise of GLP-1 medications, including Ozempic and Wegovy, has garnered significant attention in recent years, particularly among those seeking weight loss and enhanced health. Originally developed ...
Researchers suggest that a simple explanation of the benefits and harms of a medication could improve a patient’s drug of choice, according to a Dartmouth College release. Previous research suggests ...
Editor’s note: Kathy Chang is the head of trade relations at health plan Blue Shield of California. The U.S. prescription drug market produces some of the world’s most advanced pharmaceutical ...
Health and Me on MSN
Fitness first: Study claims a common drug can mimic benefits of intense workouts
Diabetes patients take metformin for regulating insulin and blood sugar levels. Read here to find out just how it mimics the benefits of intense workouts.
The vast majority of Medicare's top-selling brand-name oncology drugs in 2022 provided high added therapeutic benefit. Ten drugs were classified as low or no added therapeutic benefit compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results